Skip to content
Home/Companies/Biotech/CHASE Pharmaceuticals

CHASE Pharmaceuticals

Biotech·United States·Exited 2016·Held 2yr
Entry
2014
Hold
2yr
Exit
2016

Who owns CHASE Pharmaceuticals?

CHASE Pharmaceuticals is an American Biotech company, now owned by Allergan, which acquired it in 2016 from Andera Partners.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Andera Partners
Investor
Andera Partners
BioDiscovery 4 · 2013 · VC

Key facts

HQUnited States
SectorBiotech
Exit Type
Trade Sale
Buyer
Allergan
Exit Year
2016

More from BioDiscovery 4

Other portfolio companies in the same fund.

Inotrem
Active
BiotechFrance
MedDay Pharmaceuticals
Exited 2021
BiotechFrance· 2016
Verona Pharma
Verona Pharma
Exited 2017
BiotechUK· 2016
Autonomic Technologies
Exited 2020
MedTechUS· 2015
to Unity HA
Gamamabs
Active
BiotechFrance· 2015
ReViral
Exited 2022
BiotechUK· 2015
to Pfizer

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns CHASE Pharmaceuticals?

CHASE Pharmaceuticals is now owned by Allergan, which acquired it in 2016 from Andera Partners.

When did Allergan acquire CHASE Pharmaceuticals?

Allergan acquired CHASE Pharmaceuticals in 2016, buying from Andera Partners.

Who did CHASE Pharmaceuticals sell to?

Andera Partners sold CHASE Pharmaceuticals to Allergan in 2016 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue